Edition:
India

Histogenics Corp (HSGX.OQ)

HSGX.OQ on NASDAQ Stock Exchange Capital Market

1.86USD
15 Dec 2017
Change (% chg)

$0.05 (+2.76%)
Prev Close
$1.81
Open
$1.81
Day's High
$1.87
Day's Low
$1.80
Volume
8,395
Avg. Vol
12,929
52-wk High
$2.40
52-wk Low
$1.45

Latest Key Developments (Source: Significant Developments)

Histogenics Corp announces Q3 loss per share $0.23
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Histogenics Corp :Histogenics Corporation announces third quarter 2017 financial and operating results.Q3 loss per share $0.23.Q3 earnings per share view $-0.28 -- Thomson Reuters I/B/E/S.Histogenics Corp - ‍Potential biologics license application filing remain on track for Q3 of 2018​.Histogenics Corp - ‍Believes its current cash position will be sufficient to fund its operations into middle of 2018​.Histogenics - ‍As of September 30, 2017, co had cash, cash equivalents and marketable securities of $12.6 million, compared to $31.9 million at December 31, 2016​.  Full Article

Histogenics Corp reported Q2 EPS ($0.61)
Thursday, 11 Aug 2016 

Histogenics Corp : Q2 loss per share $0.61 . Histogenics Corporation announces second quarter 2016 financial and operating results . Q2 earnings per share view $-0.60 -- Thomson Reuters I/B/E/S .Believes its current cash position will fund its operations into Q1 of 2017.  Full Article

Histogenics Corp Q1 loss per share $0.60
Thursday, 12 May 2016 

Histogenics Corp : Histogenics Corporation announces first quarter 2016 financial and operating results . Q1 loss per share $0.60 .Q1 earnings per share view $-0.59 -- Thomson Reuters I/B/E/S.  Full Article

Histogenics buys Neocart development, commercialization rights for Japan
Tuesday, 10 May 2016 

Histogenics Corp : Assumes sole responsibility for and rights to development and commercialization of Neocart in Japan .Histogenics corporation acquires Neocart development and commercialization rights for Japanese market.  Full Article

BRIEF-Histogenics Corp announces Q3 loss per share $0.23

* Histogenics Corporation announces third quarter 2017 financial and operating results